Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Life Sciences Vital Fluids | | | | | | 1.7 | 19.7 | 17.2 |
| Revenues | | | | | | 1.7 | 19.7 | 17.2 |
| Revenue growth [+] | | | | | | -91.5% | 14.6% | 1.9% |
| Life Sciences Vital Fluids | | | | | | -91.5% | 14.6% | 1.9% |
| EBITDA | | | | | | 0.2 | 2.4 | 1.4 |
| EBITDA margin | | | | | | 9.8% | 12.1% | 8.0% |
| Depreciation and amortization | | | | | | 0.0 | 0.8 | 0.6 |
| EBIT | | | | | | 0.1 | 1.6 | 0.8 |
| EBIT margin | | | | | | 7.1% | 8.0% | 4.5% |
| |
| Capital expenditures | | | | | | 0.0 | 0.6 | 0.2 |
| |
| Total assets | | | | | | | 11.6 | 11.9 |
| ROA | | | | | | | 8.9% | 4.4% |
| |
| Revenue Mix | | | | | | 0.3% | 3.7% | 4.3% |
| EBIT Mix | | | | | | 0.2% | 4.6% | 2.7% |
|